Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr;44(4):325-341.
doi: 10.1007/s12272-021-01327-5. Epub 2021 Apr 22.

The role of mucosal barriers in human gut health

Affiliations
Review

The role of mucosal barriers in human gut health

Kangseok Seo et al. Arch Pharm Res. 2021 Apr.

Abstract

The intestinal mucosa is continuously exposed to a large number of commensal or pathogenic microbiota and foreign food antigens. The intestinal epithelium forms a dynamic physicochemical barrier to maintain immune homeostasis. To efficiently absorb nutrients from food, the epithelium in the small intestine has thin, permeable layers spread over a vast surface area. Epithelial cells are renewed from the crypt toward the villi, accompanying epithelial cell death and shedding, to control bacterial colonization. Tight junction and adherens junction proteins provide epithelial cell-cell integrity. Microbial signals are recognized by epithelial cells via toll-like receptors. Environmental signals from short-chain fatty acids derived from commensal microbiota metabolites, aryl hydrocarbon receptors, and hypoxia-induced factors fortify gut barrier function. Here we summarize recent findings regarding various environmental factors for gut barrier function. Further, we discuss the role of gut barriers in the pathogenesis of human intestinal disease and the challenges of therapeutic strategies targeting gut barrier restoration.

Keywords: Barrier function; Epithelial cell; Gut; Inflammation; Inflammatory bowel disease.

PubMed Disclaimer

References

    1. Aihara E, Engevik KA, Montrose MH (2017) Trefoil factor peptides and gastrointestinal function. Annu Rev Physiol 79:357–380. https://doi.org/10.1146/annurev-physiol-021115-105447 - DOI - PubMed
    1. Allaire JM, Crowley SM, Law HT, Chang SY, Ko HJ, Vallance BA (2019) The intestinal epithelium: central coordinator of mucosal immunity: (Trends in Immunology 39, 677–696, 2018). Trends Immunol 40(2):174. https://doi.org/10.1016/j.it.2018.12.0082018.12.008 - DOI - PubMed
    1. Angus HCK, Butt AG, Schultz M, Kemp RA (2019) Intestinal organoids as a tool for inflammatory bowel disease research. Front Med (Lausanne) 6:334. https://doi.org/10.3389/fmed.2019.00334 - DOI
    1. Artis D, Wang ML, Keilbaugh SA, He W, Brenes M, Swain GP, Knight PA, Donaldson DD, Lazar MA, Miller HR, Schad GA, Scott P, Wu GD (2004) RELMbeta/FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tract. Proc Natl Acad Sci USA 101(37):13596–13600. https://doi.org/10.1073/pnas.0404034101 - DOI - PubMed
    1. Atreya R, Bloom S, Scaldaferri F, Gerardi V, Admyre C, Karlsson A, Knittel T, Kowalski J, Lukas M, Lofberg R, Nancey S, Petryka R, Rydzewska G, Schnabel R, Seidler U, Neurath MF, Hawkey C (2016) Clinical effects of a topically applied toll-like receptor 9 agonist in active moderate-to-severe ulcerative colitis. J Crohns Colitis 10(11):1294–1302. https://doi.org/10.1093/ecco-jcc/jjw103 - DOI - PubMed - PMC

LinkOut - more resources